July 30, 2020
The Patent Trial and Appeal Board has invalidated three Antecip Bioventures pain treatment patents, shooting down its argument that German rival Grunenthal GmbH didn't do enough at the institution stage to prove that five printed publications qualify as prior art.
April 24, 2020
A Patent Trial and Appeal Board judge bristled Friday at an argument from Antecip Bioventures that more evidence is required from petitioners at the institution stage to prove the public accessibility of prior art printed publications, contrary to the board's seven-year practice.